BILL NUMBER: AB 1733	INTRODUCED
	BILL TEXT


INTRODUCED BY   Assembly Member Hill
   (Coauthors: Assembly Members Ammiano, Anderson, Block, Caballero,
Coto, Fletcher, Fong, Galgiani, Harkey, Hayashi, Audra Strickland,
Swanson, Torlakson, and Villines)
   (Coauthor: Senator Wyland)

                        FEBRUARY 4, 2010

   An act to add Section 12019.5 to the Government Code, relating to
state government.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 1733, as introduced, Hill. Director of California Biotechnology
Retention and Recruitment: duties.
   Existing law authorizes the Governor to appoint and fix the
salaries of assistants and other personnel as the Governor deems
necessary for his or her office.
   This bill would require the Governor to create, within the Office
of the Governor, the position of Director of California Biotechnology
Retention and Recruitment, as specified. The bill would make the
director responsible for serving as an informational resource for
biotechnology, life science, and medical companies, as specified.
   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  The Legislature finds and declares all of the
following:
   (a) California is home to over 2,700 biotechnology companies
employing over 260,000 people throughout the state.
   (b) California biotechnology companies are responsible for 1,200
approved treatments, and another 210 treatments are in the process of
being approved.
   (c) California companies will invest fifty billion dollars
($50,000,000,000) in manufacturing equipment, jobs, and facilities to
bring these 210 treatments to fruition.
   (d) There are more products in later-stage clinical trials in this
state than anywhere else in the world.
   (e) It takes an average of 14 years and one billion two hundred
million dollars ($1,200,000,000) to create a treatment.
   (f) A series of hearings conducted by the Assembly Select
Committee on Biotechnology during 2009 and 2010 revealed that
California biotechnology companies need assistance with complying
with regulatory requirements imposed by state and local governments.
   (g) The hearings also revealed that California biotechnology
companies are locating satellite facilities and manufacturing
facilities outside of California because other states are providing
incentives and assistance that California does not provide.
  SEC. 2.  Section 12019.5 is added to the Government Code, to read:
   12019.5.  (a) The Governor shall create within the Office of the
Governor, using existing resources, the position of Director of
California Biotechnology Retention and Recruitment. The director
shall be appointed by, report directly to, and serve at the pleasure
of, the Governor.
   (b) The director shall be responsible for both of the following:
   (1) Serving as an informational resource for biotechnology, life
science, and medical companies in this state by helping them comply
with state and local regulatory requirements.
   (2) Serving as an informational resource for biotechnology, life
science, and medical companies located outside of this state that are
interested in relocating within this state.